Lifecore Biomedical (LFCR) has signed an agreement with a global pharmaceutical company to provide technical transfer support and commercial manufacturing for an injectable neurology suspension product, the company said Monday.
The company will provide tech transfer services for the currently marketed product as part of its late-stage pipeline expansion efforts.